Helen Dooley

Title: Helen Dooley: Innovator in Antigen Binding Domains

Introduction

Helen Dooley is a notable inventor based in Baltimore, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding domains. Her innovative work has led to the filing of one patent, showcasing her expertise and dedication to advancing scientific knowledge.

Latest Patents

Helen Dooley's patent focuses on a process for the production of an antigen specific antigen binding domain. This process utilizes a transformed host containing an expressible DNA sequence that encodes the antigen specific antigen binding domain. Notably, the antigen specific antigen binding domain is derived from a variable region of the immunoglobulin isotype NAR found in fish. This innovative approach has the potential to enhance the development of targeted therapies in immunology.

Career Highlights

Throughout her career, Helen has worked with esteemed institutions such as the University System of Maryland and Aberdeen University. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Helen has had the opportunity to work alongside notable colleagues, including Andrew Porter and Martin Flajnik. Their collaborative efforts have further enriched her research and innovation in the field of antigen binding domains.

Conclusion

Helen Dooley's contributions to the field of biotechnology, particularly through her patent on antigen binding domains, highlight her role as an influential inventor. Her work continues to inspire advancements in immunology and therapeutic development.